Dendritic Cell Vaccine
MCC-21262
Phase 1 mab active
Quick answer
Dendritic Cell Vaccine for Leptomeningeal Disease is a Phase 1 program (mab) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- Leptomeningeal Disease
- Phase
- Phase 1
- Modality
- mab
- Status
- active